Dapagliflozin Polpharma

Dapagliflozin Polpharma is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which help the kidneys remove excess glucose from the body. This medication is manufactured by Zaklady Farmaceutyczne Polpharma S.A. in the EU.

Dapagliflozin Polpharma is primarily used to lower blood sugar levels in adults with type 2 diabetes. It works by helping the kidneys remove excess glucose from the body, which can improve glycemic control. This medication is often used alongside diet and exercise to manage diabetes effectively. People may wonder, 'What is Dapagliflozin used for?' and the answer is that it is designed to assist in the management of type 2 diabetes by reducing blood sugar levels.

Common effects of Dapagliflozin Polpharma may include increased urination, which is a result of the medication's mechanism of action. Some individuals may also experience symptoms such as thirst, fatigue, or dizziness. It is important to stay hydrated while taking this medication to help manage these effects. Always consult a healthcare provider for personalized advice.

Dapagliflozin Polpharma should be handled with care, especially for individuals with certain medical conditions such as kidney problems or a history of urinary tract infections. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Dapagliflozin Polpharma may interact with certain medications, including diuretics, insulin, and other drugs that affect blood sugar levels. It is also important to be cautious when consuming alcohol while taking this medication, as it can affect blood sugar levels and increase the risk of side effects. Always consult a healthcare provider for personalized advice on managing potential interactions.